ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,560,000 | -14.4% | 4,000,000 | -26.0% | 1.43% | -29.4% |
| Q1 2016 | $34,539,000 | +2.2% | 5,405,235 | 0.0% | 2.02% | -7.3% |
| Q4 2015 | $33,783,000 | +4.5% | 5,405,235 | -2.3% | 2.18% | -21.1% |
| Q3 2015 | $32,313,000 | -32.0% | 5,533,118 | -3.8% | 2.77% | -14.5% |
| Q2 2015 | $47,553,000 | -17.6% | 5,750,000 | -17.9% | 3.24% | -21.4% |
| Q1 2015 | $57,680,000 | +11.9% | 7,000,000 | -6.7% | 4.12% | +20.2% |
| Q4 2014 | $51,525,000 | +59.0% | 7,500,000 | +25.0% | 3.43% | +12.5% |
| Q3 2014 | $32,400,000 | +1.7% | 6,000,000 | +20.0% | 3.04% | +45.9% |
| Q2 2014 | $31,850,000 | +31.7% | 5,000,000 | +66.7% | 2.09% | +10.1% |
| Q1 2014 | $24,180,000 | -32.5% | 3,000,000 | -42.9% | 1.90% | -40.0% |
| Q4 2013 | $35,805,000 | – | 5,250,000 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |